When GBM cells were pre-incubated with the PKC inhibitor, Calphostin C (Calp C) immunoblotting revealed that the Wnt5a-mediated activation of ERK and NF-κB, but not JNK signalling, was blocked when PKC was neutralised (Fig. 6f). Here, WNT5A is linked to glioblastoma.